文献速递淋巴瘤

儿童伯基特淋巴瘤信号转导通路与靶点的比较基因组表达特征:儿童肿瘤协作组报告

Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.
PubMed 文献 · Br J Haematol · 2017-05-04

该研究对儿童肿瘤协作组ANHL01P1研究中儿童伯基特淋巴瘤(PEBL)样本进行基因组谱分析,并用实时定量PCR验证选定基因,再与公共数据库GEO系列GSE10172、GSE4475(n=16)及GSE4732(n=15)的PEBL样本比较。三个PEBL样本组间有376个基因(约25%)表达相似;Toll样受体、JAK-STAT和MAPK信号通路中多个靶基因及布鲁顿酪氨酸激酶等酪氨酸激酶在PEBL中高表达。这些临床前结果提示特定信号转导通路在PEBL中过度表达,部分通路可能成为未来治疗靶点。

要点

  • 三个PEBL样本组间有376个基因(约25%)表达相似。
  • Toll样受体、JAK-STAT和MAPK信号通路中多个靶基因在PEBL中显著高表达。
  • 布鲁顿酪氨酸激酶、蛋白酪氨酸磷酸酶和组蛋白去乙酰化酶抑制剂相关基因在PEBL中高表达。

核心结论

  • 这些临床前结果提示特定信号转导通路在儿童伯基特淋巴瘤中过度表达,部分通路可能成为未来治疗靶点。

研究设计与样本

  • 研究分析儿童肿瘤协作组ANHL01P1研究中儿童伯基特淋巴瘤(PEBL)样本的比较基因组特征和可靶向信号通路,采用基因组谱分析并用实时定量PCR确认选定基因。
  • 结果与公共数据库GEO系列GSE10172和GSE4475(n=16)及GSE4732(n=15)的PEBL样本进行比较。

主要发现

  • 三个PEBL样本组间有376个基因(约25%)表达相似。
  • Toll样受体信号、JAK-STAT信号和MAPK信号中多个靶基因在PEBL中显著高表达。
  • 包括布鲁顿酪氨酸激酶、蛋白酪氨酸磷酸酶和组蛋白去乙酰化酶抑制剂在内的多种酪氨酸激酶在PEBL中高表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Burkitt lymphoma (BL) is the most common histological subtype of non-Hodgkin lymphoma (NHL) in children and adolescents. Through the introduction of short intensive multi-agent chemoimmunotherapy, survival has improved significantly over the past 30 years. However, this successful approach is limited by significant chemotherapy-induced acute toxicity and risk of developing resistant disease, demonstrating the need to identify less toxic and targeted therapies. We analysed the comparative genomic signature and targetable signalling pathways in paediatric BL (PEBL) samples from the Children's Oncology Group study (ANHL01P1) by genomic profiling and selected genes were confirmed by quantitative real time polymerase chain reaction. These results were compared to PEBL samples from public databases and utilised the Gene Expression Omnibus (GEO) Series (GSE) 10172 and 4475 (n = 16), and 4732 (n = 15). Three hundred and seventy-six genes (approximately 25%) were similarly expressed among three PEBL sample groups. Several target genes in Toll-like receptor signalling, JAK-STAT signalling and MAPK signalling were significantly overexpressed in PEBL. In addition, several tyrosine kinases, including Bruton tyrosine kinase, protein tyrosine phosphatase and histone deacetylase inhibitor were highly expressed in PEBL. These pre-clinical results suggest that specific signal transduction pathways are overly expressed in PEBL and several pathways could serve as potential future therapeutic targets.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Lee S, Day NS, Miles RR, et al. Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report. Br J Haematol. 2017. PMID: 28474336. doi:10.1111/bjh.14604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。